For example, the potential role of cagrilintide in improving insulin sensitivity, reducing cardiovascular risk markers and regulating energy expenditure may offer therapeutic benefits in brain disorders exacerbated by metabolic impairments, such as Alzheimer’s disease [47,175,176,177,178,179]. This evidence concerns the gene INS and brain disorder.